House dust mite reduction and avoidance measures for treating eczema (Q24186585)

1

0 references

Emma V Pynn

2

0 references

Robert J Boyle

3

0 references

Lesley Rushton

4

0 references

Hywel C Williams

5

0 references

Deanne M Hewson

Cochrane Database of Systematic Reviews

6

0 references

publication date

19 January 2015

0 references

published in

0 references

cites work

Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Mite elimination--clinical effect on eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

House dust mite allergen reduction and allergy at 4 yr: follow up of the PIAMA-study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

IL-5 T-cell responses to house dust mite are associated with the development of allergen-specific IgE responses and asthma in the first 5 years of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

The biology of dust mites and the remediation of mite allergens in allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Dietary exclusions for established atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Delay of growth and development in children with bronchial asthma, atopic dermatitis and allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Allergen sensitization through the skin induces systemic allergic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Interventions to reduce Staphylococcus aureus in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Allergy development and the intestinal microflora during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Probiotics for treating eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Air pollution and development of asthma, allergy and infections in a birth cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Outcome measures of disease severity in atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Topical corticosteroid phobia in patients with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Cost of atopic dermatitis and eczema in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Severity distribution of atopic dermatitis in the community and its relationship to secondary referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

What is the cost of atopic dermatitis in preschool children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

How atopic is atopic dermatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Dust mite avoidance in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

House dust mite control measures for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Cost of illness of atopic dermatitis in children: a societal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

What causes worsening of eczema? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

The socioeconomic impact of atopic dermatitis in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Sleep disruptions in parents of children and adolescents with chronic illnesses: prevalence, causes, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Association of Filaggrin loss-of-function-mutations with atopic dermatitis and asthma in the Early Treatment of the Atopic Child (ETAC) population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

House dust mite avoidance measures for perennial allergic rhinitis: an updated Cochrane systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Long-term exposure to background air pollution related to respiratory and allergic health in schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Allergen avoidance in the treatment of asthma: problems with the meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Atopic eczema: its impact on the family and financial cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

21 January 2018

Early events in atopy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

The cost of atopic dermatitis in the Netherlands: an international comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

How epidemiology has challenged 3 prevailing concepts about atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Guidelines of care for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Basophils in allergen-induced patch test sites in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Importance of inhalant allergens in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Mite allergen (Der p 1) levels in houses of children with atopic dermatitis: the relationship with allergometric tests

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Effect of house dust mite avoidance measures in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Evaluation of impermeable covers for bedding in patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Atopic dermatitis and the clinical effect of house dust mite avoidance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

A controlled trial of house dust mite eradication using natamycin in homes of patients with atopic dermatitis: effect on clinical status and mite populations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

The role of dust mite allergens in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Patch testing to aeroallergens, especially house dust mite, is often positive in atopics with eczema of the face and hands

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Atopic march to a dead end or does the theory really have legs?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

Systematic review of treatments for atopic eczema.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008426.PUB2

7 January 2021

10.1002/14651858.CD008426.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2248532

2248532

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference